发明申请
- 专利标题： AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS
- 专利标题（中）： 氨基嘧啶可用作激酶抑制剂
-
申请号： US12598276申请日： 2009-10-30
-
公开(公告)号： US20100215772A1公开(公告)日： 2010-08-26
- 发明人: Michael Mortimore , Julian M.C. Golec , Daniel David Robinson , John Studley
- 申请人： Michael Mortimore , Julian M.C. Golec , Daniel David Robinson , John Studley
- 申请人地址： US MA Cambridge
- 专利权人： VERTEX PHARMACEUTICALS INCORPORATED
- 当前专利权人： VERTEX PHARMACEUTICALS INCORPORATED
- 当前专利权人地址： US MA Cambridge
- 主分类号： A61K33/24
- IPC分类号： A61K33/24 ; C07D239/46 ; A61K31/495 ; A61K31/506 ; A61K31/517 ; A61K31/5377 ; A61K31/513 ; A61P35/00
摘要：
The present invention relates to compounds useful as inhibitors of Aurora protein kinases. The invention also provides pharmaceutically acceptable compositions comprising those compounds and methods of using the compounds and compositions in the treatment of various disease, conditions, and disorders. The invention also provides processes for preparing compounds of the invention.
公开/授权文献
- US08383633B2 Aminopyrimidines useful as kinase inhibitors 公开/授权日：2013-02-26
信息查询
